Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
LipRSV modulated oxidative stress in a region-dependent manner without improving behavioral deficits in the VPA model and was associated with reduced BDNF and NGF levels
Phase III randomized, placebo-controlled trial of endocrine therapy 1 year of everolimus in patients with high-risk, hormone receptor-positive, early-stage breast cancer
This has potential relevance for circulatory conditions, but human data is limited
Referral thresholds are broadly guided by NICE but may vary according to local NHS Integrated Care System (ICS) policies
No lethal dose was identified across a wide dose range from 0.006 mg/kg to 20 mg/kg body weight
The FDA review process typically takes 10 to 12 months from filing, meaning a potential approval decision could come in late this year or early next year
US$ 21.15
US$ 23.06
US$ 27.64
US$ 29.06
US$ 20.09
